Arzoxifene as therapy for endometrial cancer.

Gynecologic oncology

Volumn 90, Issue 2 Pt 2, 2003, Pages

  Burke, Thomas W ^a   Walker, Cheryl L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ARZOXIFENE; PIPERIDINE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THIOPHENE DERIVATIVE;

ENDOMETRIUM TUMOR; FEMALE; HUMAN; METABOLISM; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MULTICENTER STUDIES; PIPERIDINES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; THIOPHENES;

MLCS; MLOWN;

EID: 13844286452     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-8258(03)00343-3     Document Type: Review

References (55)